These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24046231)

  • 21. The pathogenesis of psoriatic arthritis.
    Veale DJ; Fearon U
    Lancet; 2018 Jun; 391(10136):2273-2284. PubMed ID: 29893226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors for clinical outcome in psoriatic arthritis - what have we learned from cohort studies?
    Eder L; Gladman DD
    Expert Rev Clin Immunol; 2014 Jun; 10(6):763-70. PubMed ID: 24702706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apremilast for the treatment of psoriatic arthritis.
    Souto A; Gómez-Reino JJ
    Expert Rev Clin Immunol; 2015; 11(12):1281-90. PubMed ID: 26503917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease.
    McGonagle D
    J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():9-13. PubMed ID: 19686380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone remodeling in psoriasis and psoriatic arthritis: an update.
    Paine A; Ritchlin C
    Curr Opin Rheumatol; 2016 Jan; 28(1):66-75. PubMed ID: 26555451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenetic overview of psoriatic disease.
    Haroon M; Fitzgerald O
    J Rheumatol Suppl; 2012 Jul; 89():7-10. PubMed ID: 22751581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of cytokine production in psoriatic synovium.
    Ritchlin C; Haas-Smith SA; Hicks D; Cappuccio J; Osterland CK; Looney RJ
    J Rheumatol; 1998 Aug; 25(8):1544-52. PubMed ID: 9712099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
    Novelli L; Chimenti MS; Chiricozzi A; Perricone R
    Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current concepts in psoriatic arthritis: pathogenesis and management.
    de Vlam K; Gottlieb AB; Mease PJ
    Acta Derm Venereol; 2014 Nov; 94(6):627-34. PubMed ID: 24573106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of IL-17 in psoriasis and psoriatic arthritis.
    Raychaudhuri SP
    Clin Rev Allergy Immunol; 2013 Apr; 44(2):183-93. PubMed ID: 22362575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psoriatic arthritis.
    Ocampo D V; Gladman D
    F1000Res; 2019; 8():. PubMed ID: 31583079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics focusing on immune markers in psoriatic arthritis.
    Caruntu C; Boda D; Dumitrascu G; Constantin C; Neagu M
    Biomark Med; 2015; 9(6):513-28. PubMed ID: 25034152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis.
    Wenink MH; Santegoets KC; Butcher J; van Bon L; Lamers-Karnebeek FG; van den Berg WB; van Riel PL; McInnes IB; Radstake TR
    Arthritis Rheum; 2011 Nov; 63(11):3313-22. PubMed ID: 21811995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Update in the pathogenesis of psoriatic arthritis].
    González S; Queiro R; Ballina J
    Reumatol Clin; 2012 Mar; 8 Suppl 1():S1-6. PubMed ID: 22285206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine targeting in psoriasis and psoriatic arthritis: beyond TNFalpha.
    MclInnes IB
    Ernst Schering Res Found Workshop; 2006; (56):29-44. PubMed ID: 16329645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psoriatic arthritis from a mechanistic perspective.
    Schett G; Rahman P; Ritchlin C; McInnes IB; Elewaut D; Scher JU
    Nat Rev Rheumatol; 2022 Jun; 18(6):311-325. PubMed ID: 35513599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-17 cytokines: Effectors and targets in psoriasis-A breakthrough in understanding and treatment.
    Prinz I; Sandrock I; Mrowietz U
    J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31727784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of psoriasis-associated arthritis and skin lesions by treatment with molecular hydrogen: A report of three cases.
    Ishibashi T; Ichikawa M; Sato B; Shibata S; Hara Y; Naritomi Y; Okazaki K; Nakashima Y; Iwamoto Y; Koyanagi S; Hara H; Nagao T
    Mol Med Rep; 2015 Aug; 12(2):2757-64. PubMed ID: 25936373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.
    Raychaudhuri SK; Saxena A; Raychaudhuri SP
    Clin Rheumatol; 2015 Jun; 34(6):1019-23. PubMed ID: 25939522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathogenesis of psoriasis and psoriatic arthritis and pharmacological perspectives.
    Loffredo S; Ayala F; Marone GC; Genovese A; Marone G
    Reumatismo; 2007; 59 Suppl 1():28-39. PubMed ID: 17828356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.